In the BioHarmony Drug Report Database

"Preview" Icon

Asfotase alfa

Strensiq (asfotase alfa) is an enzyme pharmaceutical. Asfotase alfa was first approved as Strensiq on 2015-08-28. It is used to treat hypophosphatasia in the USA. It has been approved in Europe to treat hypophosphatasia.

 

Trade Name

 

Strensiq
 

Common Name

 

asfotase alfa
 

ChEMBL ID

 

CHEMBL2108311
 

Indication

 

hypophosphatasia
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Asfotase alfa structure rendering